Sean Lavin
Stock Analyst at BTIG
(3.08)
# 1,269
Out of 4,967 analysts
45
Total ratings
81.82%
Success rate
38.68%
Average return
Main Sectors:
Stocks Rated by Sean Lavin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TCMD Tactile Systems Technology | Downgrades: Neutral | n/a | $13.45 | - | 4 | Nov 5, 2024 | |
| HOLX Hologic | Downgrades: Neutral | n/a | $66.62 | - | 5 | Jul 18, 2022 | |
| PODD Insulet | Upgrades: Buy | $320 | $344.92 | -7.22% | 5 | Feb 3, 2022 | |
| MDT Medtronic | Downgrades: Neutral | n/a | $93.33 | - | 1 | Jan 10, 2022 | |
| ATRC AtriCure | Maintains: Buy | $42 → $48 | $36.27 | +32.34% | 3 | Feb 19, 2020 | |
| MASI Masimo | Downgrades: Neutral | n/a | $137.67 | - | 4 | Apr 16, 2019 | |
| HSDT Helius Medical Technologies | Downgrades: Neutral | n/a | $6.09 | - | 4 | Apr 16, 2019 | |
| IRTC iRhythm Technologies | Upgrades: Buy | $80 | $171.06 | -53.23% | 3 | Apr 3, 2019 | |
| NEO NeoGenomics | Upgrades: Outperform | n/a | $8.81 | - | 4 | Apr 16, 2018 | |
| EXAS Exact Sciences | Upgrades: Buy | n/a | $48.01 | - | 3 | Apr 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $131.46 | - | 1 | Jan 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $106.66 | - | 1 | Nov 30, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $74.30 | - | 3 | May 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $81.77 | - | 4 | Feb 2, 2017 |
Tactile Systems Technology
Nov 5, 2024
Downgrades: Neutral
Price Target: n/a
Current: $13.45
Upside: -
Hologic
Jul 18, 2022
Downgrades: Neutral
Price Target: n/a
Current: $66.62
Upside: -
Insulet
Feb 3, 2022
Upgrades: Buy
Price Target: $320
Current: $344.92
Upside: -7.22%
Medtronic
Jan 10, 2022
Downgrades: Neutral
Price Target: n/a
Current: $93.33
Upside: -
AtriCure
Feb 19, 2020
Maintains: Buy
Price Target: $42 → $48
Current: $36.27
Upside: +32.34%
Masimo
Apr 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $137.67
Upside: -
Helius Medical Technologies
Apr 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $6.09
Upside: -
iRhythm Technologies
Apr 3, 2019
Upgrades: Buy
Price Target: $80
Current: $171.06
Upside: -53.23%
NeoGenomics
Apr 16, 2018
Upgrades: Outperform
Price Target: n/a
Current: $8.81
Upside: -
Exact Sciences
Apr 3, 2018
Upgrades: Buy
Price Target: n/a
Current: $48.01
Upside: -
Jan 22, 2018
Downgrades: Neutral
Price Target: n/a
Current: $131.46
Upside: -
Nov 30, 2017
Upgrades: Buy
Price Target: n/a
Current: $106.66
Upside: -
May 3, 2017
Downgrades: Neutral
Price Target: n/a
Current: $74.30
Upside: -
Feb 2, 2017
Downgrades: Neutral
Price Target: n/a
Current: $81.77
Upside: -